Dec 17, 2025
Gastrointestinal Combination Products: Generic Availability and Alternatives
Tag: Paragraph IV certification
30-Month Stay Explained: How Patent Litigation Delays Generic Drug Approval
Read More
Explore how the 30-month stay under the Hatch-Waxman Act delays generic drug approval through patent litigation, impacting costs and market access.
